Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review.

Patient Preference and Adherence
Alessandra Graziottin

Abstract

The worldwide introduction of the first, unique patch for hormonal contraception (ethinyl estradiol/norelgestromin, EE/NGMN patch) was widely recognized as a significant event in the development of drug delivery systems. This innovation offers a number of advantages over the oral route, and extensive clinical trials have proved its safety, efficacy, effectiveness, and tolerability. The weekly administration and ease of use/simplicity of the EE/NGMN patch contribute to its acceptability, and help to resolve the two main problems of non-adherence, namely early discontinuation and inconsistent use. The patch offers additional benefits to adolescents (improvement of dysmenorrhea and acne), adults (improvement in emotional and physical well-being, premenstrual syndrome, and menstrual irregularities), and perimenopausal women (correction of hormonal imbalance, modulation of premenopausal symptoms), thus providing high satisfaction rates (in nearly 90% of users). Since its introduction, the transdermal contraceptive patch has proved to be a useful choice for women who seek a convenient formulation which is easy to use, with additional, non-contraceptive tailored benefits for all the ages.

References

Aug 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·P Warner, J Bancroft
May 1, 1995·The Journal of Reproductive Medicine·M J RosenbergS Long
Nov 1, 1993·American Journal of Public Health·A Terefe, C P Larson
Jan 26, 1999·Clinical Obstetrics and Gynecology·C Schmidt-Sarosi
Nov 15, 2000·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·T RabeS Rehberger-Schneider
Nov 25, 2000·Obstetrics and Gynecology Clinics of North America·J T Jensen, L Speroff
May 10, 2001·JAMA : the Journal of the American Medical Association·M C AudetUNKNOWN ORTHO EVRA/EVRA 004 Study Group
Aug 25, 2001·American Journal of Obstetrics and Gynecology·A M Kaunitz
Nov 13, 2001·Obstetrics and Gynecology·G H SmallwoodUNKNOWN ORTHO EVRA/EVRA 002 Study Group
Dec 1, 2001·Seminars in Reproductive Medicine·G W CreasyA C Fisher
Jan 26, 2002·American Journal of Obstetrics and Gynecology·Richard DittrichUNKNOWN Ortho Evra/Evra 001 Study Group
Feb 19, 2002·Fertility and Sterility·Howard A ZacurGeorge W Creasy
Jun 5, 2003·International Family Planning Perspectives·Saumya RamaRaoHeidi Jones
Mar 26, 2004·Nature Reviews. Drug Discovery·Mark R PrausnitzRobert Langer
Apr 20, 2004·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Mark L RubinsteinCharles E Irwin
Jan 27, 2005·American Journal of Obstetrics and Gynecology·Frank A SonnenbergC Greg Hagerty
May 18, 2005·Journal of Pediatric and Adolescent Gynecology·Zeev HarelDalia Harel
Aug 2, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Wolfgang UrdlUNKNOWN ORTHO EVRA/EVRA 003 Study Group
Sep 13, 2005·Journal of Midwifery & Women's Health·Janice D Smith, Deborah Oakley
Mar 15, 2006·Health Education & Behavior : the Official Publication of the Society for Public Health Education·Katrina M Walsemann, Anthony Daniel Perez
Feb 3, 2007·Obstetrics and Gynecology·J Alexander ColeAlexander M Walker
Mar 17, 2007·Contraception·George J WanDiana D McDonnell
Apr 4, 2007·American Journal of Obstetrics and Gynecology·Carolyn L WesthoffDebra Kalmuss
May 17, 2007·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Françoise ParisCharles Sultan
Aug 11, 2007·American Journal of Obstetrics and Gynecology·Ronald T Burkman
Nov 6, 2007·Clinical Obstetrics and Gynecology·Katharine O'Connell, Ronald T Burkman
Jan 9, 2008·Seminars in Reproductive Medicine·Bulent O Yildiz
Jan 19, 2008·Expert Opinion on Pharmacotherapy·Allison K Rodgers, Tommaso Falcone
Feb 2, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Joyce A CramerPeter K Wong

❮ Previous
Next ❯

Citations

Oct 21, 2011·Infectious Diseases in Obstetrics and Gynecology·Venkatesan ChakrapaniRobert Dubrow
Feb 2, 2016·Advanced Drug Delivery Reviews·R Karl MalcolmDiarmaid J Murphy
Dec 15, 2010·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·A J JakimiukE J Lee
May 13, 2015·PloS One·Peter BoydR Karl Malcolm

❮ Previous
Next ❯

Methods Mentioned

BETA
contraception

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.